This article is more than 5 years old. Information may no longer be current.

TearLab reports $2 million second-quarter net loss

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

TearLab reported a net loss of $1.97 million for the second quarter, an improvement over the $4.8 million net loss in the same period last year, according to a news release.

TearLab reported net revenues of $716,000 for the quarter, a 53% increase compared to net revenues for the second quarter of 2011.

The company anticipates a boost in revenues related to its TearLab Osmolarity System, which was launched in April.

“As we record revenues when a doctor is able to use our device as opposed to when we sell it, our strong sales performance is not yet reflected in our revenues,” Elias Vamvakas, chief executive officer of TearLab, said.

The company increased its sales and marketing expenses to $960,000 in the second quarter of 2012, compared to $433,000 in the second quarter of 2011, according to the release.

TearLab has $13.4 million in cash, not including approximately $7.4 million in net funds raised in a registered financing in July, the release said.